Specific Biologics' mission is to develop novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
We are actively developing a platform technology consisting of a dual-cleaving nuclease that can be safely delivered to cells for the treatment of various genetic diseases. This technology is designed to better exploit the cell's naturally occurring DNA repair pathways through enhanced repair or predictable deletions.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 661 University Ave, Toronto,ontario M5g 0b7,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- specificbiologics.com
- Keywords
- strategic insight to the team..
- HQ
- Toronto, Ontario
Specific Biologics Questions
Specific Biologics's website is specificbiologics.com
Specific Biologics's LinkedIn profile is https://ca.linkedin.com/company/specific-biologics
Specific Biologics has
18 employees.
View email and phone details for 18
employees at Specific Biologics.
Specific Biologics's industry is
Biotechnology Research
Specific Biologics's top competitors are
Amacathera,
Bluerock Therapeutics,
Ccrm,
Omniabio,
Radiant Biotherapeutics,
Notch Therapeutics,
Find Therapeutics,
Thryv Therapeutics Inc.,
Deep Genomics,
Jenthera Therapeutics Inc..
Specific Biologics's categories are Biotechnology Research
Specific Biologics's founding year is 2017
